Cargando…

POSB12 Association Between Remdesivir Treatment and In-Hospital All-Cause Mortality Among Patients Hospitalized with COVID-19

Detalles Bibliográficos
Autores principales:	Mozaffari, E, Zhang, Z, Thrun, M, Gottlieb, RL, Kuritzkes, DR, Sax, PE, Wohl, D, Casciano, R, Hodgkins, P, Haubrich, R, Chandak, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769620/ http://dx.doi.org/10.1016/j.jval.2021.11.122

Ejemplares similares

38. Remdesivir Treatment in Patients Hospitalized with COVID-19: A Comparative Analysis of In-Hospital All-Cause Mortality
por: Mozaffari, Essy, et al.
Publicado: (2021)

Remdesivir Treatment in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): A Comparative Analysis of In-hospital All-cause Mortality in a Large Multicenter Observational Cohort
por: Mozaffari, Essy, et al.
Publicado: (2021)

POSB13 Thirty-Day Readmission in US Hospitalized COVID-19 Patients
por: Mozaffari, E, et al.
Publicado: (2022)

Clinical Management of Hospitalized Coronavirus Disease 2019 Patients in the United States
por: Mozaffari, Essy, et al.
Publicado: (2021)

PIN82 Real-World Utilization of Remdesivir in 2020: A Retrospective Cohort Study
por: Mozaffari, E., et al.
Publicado: (2021)

Comparative effectiveness research in COVID-19 using real-world data: methodological considerations
por: Read, Stephanie H, et al.
Publicado: (2021)

536. Clinical Outcomes of Hospitalized COVID-19 Patients Treated with Remdesivir-NEAT ID 909REM Study
por: Raffi, François, et al.
Publicado: (2021)

POSB103 COVID-19 Positive Patients Hospital Management in the Italian Setting: The Economic Impact
por: Ferrario, LB, et al.
Publicado: (2022)

Association of Remdesivir Treatment With Mortality Among Hospitalized Adults With COVID-19 in the United States
por: Chokkalingam, Anand P., et al.
Publicado: (2022)

POSB193 COVID-19 Vaccine Development Pipeline: 2021
por: Ahlawat, R, et al.
Publicado: (2022)

POSB178 Geographical Inequalities in Coronavirus (SARS-COV-2) Mortality in Europe
por: Elmer, D, et al.
Publicado: (2022)

POSB398 Kaplan-Meier Survival Curves Analysis of Hospitalized COVID-19 Beneficiaires of a Health Care Plan in Brazil
por: Reis Neto, JP, et al.
Publicado: (2022)

POSB223 Impact of the COVID-19 Pandemic on Influenza Vaccination Policies
por: Net, P, et al.
Publicado: (2022)

POSB255 Enough with the Madness! Hydroxychloroquine Is NOT a Treatment for COVID-19.
por: Santos, A, et al.
Publicado: (2022)

POSB360 Perception of COVID-19 Vaccination Among Chronic Patients: To Be or Not to Be Vaccinated?
por: Vives, A, et al.
Publicado: (2022)

Remdesivir for Hospitalized COVID-19 Patients in the United States: Optimization of Health Care Resources
por: Barnieh, Lianne, et al.
Publicado: (2023)

Remdesivir Is Associated With Reduced Mortality in COVID-19 Patients Requiring Supplemental Oxygen Including Invasive Mechanical Ventilation Across SARS-CoV-2 Variants
por: Mozaffari, Essy, et al.
Publicado: (2023)

POSB396 Identification of Risk Factors Associated with ICU Admission in COVID-19 Patients
por: Kukreja, I, et al.
Publicado: (2022)

POSB27 Results of Self-Reported EHR COVID Screenings Among Community Oncology Patients
por: Mohammad, N, et al.
Publicado: (2022)

POSB33 Comorbidities, Oxygen Therapy Use and Rehospitalization in US Patients with Severe COVID-19
por: Jhamb, S, et al.
Publicado: (2022)

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
por: Kalil, Andre C., et al.
Publicado: (2020)

The Cost-Effectiveness of Remdesivir for Hospitalized Patients With COVID-19
por: Whittington, Melanie D., et al.
Publicado: (2022)

Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients
por: Coelho, Luís, et al.
Publicado: (2023)

POSB240 The Effects of COVID-19 Infection on Medication Adherence with Chronic Therapies in Italy: The Fail-to-Refill Project
por: Degli, Esposti L, et al.
Publicado: (2022)

Adherence to antiretroviral treatment regimens and correlation with risk of hospitalization among commercially insured HIV patients in the US
por: Sax, PE, et al.
Publicado: (2010)

POSB57 Budget Impact Analysis of XprESS to Treat Sinus and Eustachian Tube Dysfunction in Spain: Positive Impact on the Care Pathway with Reduced Costs and Increased Hospital Capacity
por: Manzano, C, et al.
Publicado: (2022)

Greek Remdesivir Cohort (GREC) Study: Effectiveness of Antiviral Drug Remdesivir in Hospitalized Patients with COVID-19 Pneumonia
por: Petrakis, Vasilis, et al.
Publicado: (2022)

Hospital Length of Stay for Patients with Severe COVID-19: Implications for Remdesivir’s Value
por: Anderson, Michaela R., et al.
Publicado: (2020)

Population Pharmacokinetics of Remdesivir and GS-441524 in Hospitalized COVID-19 Patients
por: Leegwater, E., et al.
Publicado: (2022)

POSB242 Telemedicine Use During Year 2020 of the COVID-19 Pandemic in Older US Medicare Beneficiaries
por: Davis-Ajami, ML, et al.
Publicado: (2022)

Occupational Therapy in Mental Hospitals
por: Hodgkins, Dorothy
Publicado: (1928)

Association of Treatment with Remdesivir and 30-day Hospital Readmissions in Patients Hospitalized with COVID-19
por: Finn, Arkadiy, et al.
Publicado: (2022)

Real-life use of remdesivir in hospitalized patients with COVID-19
por: Garcia-Vidal, Carolina, et al.
Publicado: (2021)

Remdesivir modifies interferon response in hospitalized COVID-19 patients
por: Murphy, Sarah L., et al.
Publicado: (2022)

Remdesivir: Sinus bradycardia: 12 case reports
Publicado: (2022)

Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19
por: Ohl, Michael E., et al.
Publicado: (2021)

Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial
por: Rosas, Ivan O., et al.
Publicado: (2021)

POSB425 Methodological Challenges to Coronavirus Disease (COVID-19) Evidence Generation to Inform Health Technology Assessment (HTA)
por: Rtveladze, K, et al.
Publicado: (2022)

POSB266 NICE Published Oncology Recommendations: What Progress Has Been Made During the COVID-19 Era?
por: Samuels, E, et al.
Publicado: (2022)

POSB174 Clinical and Economic Impact of Non-Pharmacological Interventions on the COVID-19 Pandemic: A Predictive Model Based on the Spanish Case
por: Viayna, E, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6tjs0jlkniueamsufbhagdgm8i